These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7173949)

  • 1. Sensitivity of cultured pancreatic carcinoma cells to Acinetobacter glutaminase-asparaginase.
    Wu MC; Arimura GK; Holcenberg JS; Yunis AA
    In Vitro; 1982 Sep; 18(9):750-4. PubMed ID: 7173949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase.
    Wu MC; Arimura GK; Yunis AA
    Int J Cancer; 1978 Dec; 22(6):728-33. PubMed ID: 363626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I evaluation of succinylated Acinetobacter glutaminase-asparaginase in adults.
    Warrell RP; Chou TC; Gordon C; Tan C; Roberts J; Sternberg SS; Philips FS; Young CW
    Cancer Res; 1980 Dec; 40(12):4546-51. PubMed ID: 7438089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of melphalan therapy with glutaminase:asparaginase.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):83-92. PubMed ID: 725323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.
    Warrell RP; Arlin ZA; Gee TS; Chou TC; Roberts J; Young CW
    Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of succinylated Acinetobacter glutaminase-asparaginase treatment on an acute myeloid leukemia in the rat (BNML).
    Sonneveld P; Holcenberg JS; van Bekkum DW
    Eur J Cancer (1965); 1979 Aug; 15(8):1061-3. PubMed ID: 292598
    [No Abstract]   [Full Text] [Related]  

  • 7. Antineoplastic and toxic effects of Acinetobacter and Pseudomonas glutaminase-asparaginases.
    Schmid FA; Roberts J
    Cancer Chemother Rep; 1974; 58(6):829-40. PubMed ID: 4447925
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginase.
    Holcenberg JS
    Cancer Treat Rep; 1979 Jun; 63(6):1109-14. PubMed ID: 466650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Acinetobacter glutaminase-asparaginase treatment on free amino acids in mouse tissues.
    Holcenberg JS; Tang E; Dolowy WC
    Cancer Res; 1975 May; 35(5):1320-5. PubMed ID: 1091350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid utilization and urine protein excretion in children treated with succinylated Acinetobacter glutaminase-asparaginase.
    Kien CL; Holcenberg JS
    Cancer Res; 1981 Jun; 41(6):2056-62. PubMed ID: 7016307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutaminase induced prolonged regression of established Ehrlich carcinoma.
    Roberts J; Holcenberg JS; Dolowy WC
    Life Sci II; 1971 Mar; 10(5):251-5. PubMed ID: 4930322
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue nitrogen-sparing effect of high protein diet in mice with or without ascites tumor treated with Acinetobacter glutaminase-asparaginase.
    Kien CL; Anderson AJ; Holcenberg JS
    Cancer Res; 1985 Oct; 45(10):4876-82. PubMed ID: 4027974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase.
    Blachier J; Cleret A; Guerin N; Gil C; Fanjat JM; Tavernier F; Vidault L; Gallix F; Rama N; Rossignol R; Piedrahita D; Andrivon A; Châlons-Cottavoz M; Aguera K; Gay F; Horand F; Laperrousaz B
    Exp Cell Res; 2023 May; 426(2):113568. PubMed ID: 36967104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of asparaginase on cell membranes of sensitive and resistant mouse lymphoma cells.
    Ankel EG; Zirneski J; Ring BJ; Holcenberg JS
    In Vitro; 1984 May; 20(5):376-84. PubMed ID: 6724617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic activity of highly purified bacterial glutaminases.
    Roberts J; Holcenberg JS; Dolowy WC
    Nature; 1970 Sep; 227(5263):1136-7. PubMed ID: 4915990
    [No Abstract]   [Full Text] [Related]  

  • 16. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase.
    Yunis AA; Arimura GK; Russin DJ
    Int J Cancer; 1977 Jan; 19(1):128-35. PubMed ID: 832918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and properties of L-glutaminase-L-asparaginase from Pseudomonas acidovorans.
    Davidson L; Brear DR; Wingard P; Hawkins J; Kitto GB
    J Bacteriol; 1977 Mar; 129(3):1379-86. PubMed ID: 845119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
    Riley V; Spackman D; Fitzmaurice MA; Roberts J; Holcenberg JS; Dolowy WC
    Cancer Res; 1974 Feb; 34(2):429-38. PubMed ID: 4810909
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors.
    Taylor CW; Dorr RT; Fanta P; Hersh EM; Salmon SE
    Cancer Chemother Pharmacol; 2001; 47(1):83-8. PubMed ID: 11221967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid sequence of the diazooxonorleucine binding site of Acinetobacter and Pseudomonas 7A glutaminase--asparaginase enzymes.
    Holcenberg JS; Ericsson L; Roberts J
    Biochemistry; 1978 Feb; 17(3):411-7. PubMed ID: 619999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.